COMPASS Pathways (CMPS) Price & Analysis

Compare

2,084 Followers

CMPS Stock Chart & Stats

Day’s Range― - ―

52-Week Range$2.25 - $7.53

Previous CloseN/A

Volume477.34K

Average Volume (3M)1.96M

Market Cap

$472.61M

Enterprise Value$74.38M

Total Cash (Recent Filing)$222.26M

Total Debt (Recent Filing)$35.29M

Price to Earnings (P/E)―

Beta1.50

Next Earnings

Oct 30, 2025

EPS Estimate

-0.4

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.41

Shares Outstanding95,941,260

10 Day Avg. Volume2,053,683

30 Day Avg. Volume1,964,072

Financial Highlights & Ratios

PEG Ratio1.91

Price to Book (P/B)1.65

Price to Sales (P/S)0.00

P/FCF Ratio-2.14

Enterprise Value/Market Cap0.16

Enterprise Value/RevenueN/A

Enterprise Value/Gross Profit-465.28

Enterprise Value/Ebitda-0.53

Forecast

1Y Price Target

$15.44

Price Target Upside194.66% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering9

Bulls Say, Bears Say

Bulls Say

Earnings And Financial PositionCOMPASS ended the quarter with $221.9 million in cash, extending its runway into 2027 and enabling continued investment in TRD, PTSD, and commercial readiness.

Market ValuationShares are considered oversold based on recent data, suggesting potential for growth.

Regulatory ProgressThe company's decision to protect against the risk of patient unblinding in trials addresses key concerns of the FDA in psychedelic trials.

Bears Say

Market ReactionThe market’s muted reaction to the COMP005 trial results—CMPS is down 20% since the data release—misrepresents the trial’s success, which provides a validated safety baseline and a credible efficacy signal.

Stock PerformanceCMPS shares sank ~45% on the news and have barely recovered.

COMPASS Pathways News

Psychedelic: Bright Minds reports preclinical BMB-201 results

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on...

8d ago

CMPS

CYBN

Compass Pathways’ COMP360 psilocybin shows positive efficacy, tolerance results

Compass Pathways (CMPS) announced the publication of results from an open-label Phase 2 study evaluating the safety and...

11d ago

CMPS

Psychedelic: Exclusive talk with biopharma company Reunion Neuroscience

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Greg Mayes, President and Chief Executive...

15d ago

ATAI

CMND

Positive Clinical Results and Strategic Advancements Drive Buy Rating for COMPASS Pathways

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on COMPASS Pathways today and set a price target...

9h ago

CMPS

Compass Pathways’ Phase III Study on COMP360: A Potential Game-Changer for Depression Treatment

Compass Pathways Plc (($CMPS)) announced an update on their ongoing clinical study. Compass Pathways Plc is currently conducting...

21d ago

CMPS

Compass Pathways’ Phase III Study on COMP360: A Potential Game-Changer for Treatment-resistant Depression

Compass Pathways Plc (($CMPS)) announced an update on their ongoing clinical study. Compass Pathways Plc is conducting a...

23d ago

CMPS

Optimistic Buy Rating for COMPASS Pathways Amidst Promising Phase 3 Trials and Regulatory Support

Canaccord Genuity analyst Sumant Kulkarni has maintained their bullish stance on CMPS stock, giving a Buy rating on...

29d ago

CMPS

Cathie Wood ‘Buys the Dip’ in Block Stock; Sells Shopify Shares

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) bought $19.2 million worth of Block stock ($XYZ) yesterday, according to ARK’s daily...

1M ago

XYZ

Psychedelic: Cybin receives European approval for EMBRACE study

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on...

1M ago

CMND

CMPS

Compass Pathways’ Phase III Study on COMP360: A New Hope for Treatment-resistant Depression

Compass Pathways Plc (($CMPS)) announced an update on their ongoing clinical study. Compass Pathways Plc is conducting a...

1M ago

CMPS

COMPASS Pathways: Leading the Psychedelic Medicine Revolution with Promising Psilocybin Trials and Strong Industry Positioning

Michael Okunewitch, an analyst from Maxim Group, maintained the Buy rating on COMPASS Pathways. The associated price target...

1M ago

CMPS

Compass Pathways’ COMP360 Study: A New Hope for Treatment-resistant Depression?

Compass Pathways Plc (($CMPS)) announced an update on their ongoing clinical study. Compass Pathways Plc is conducting a...

1M ago

CMPS

Compass Pathways price target lowered to $40 from $45 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Compass Pathways (CMPS) to $40 from $45 and keeps a...

1M ago

CMPS

Compass Pathways’ Phase III Study on COMP360: A Potential Breakthrough in Treating Depression

Compass Pathways Plc (($CMPS)) announced an update on their ongoing clinical study. Compass Pathways Plc is conducting a...

1M ago

CMPS

CMPS FAQ

What was COMPASS Pathways’s price range in the past 12 months?

COMPASS Pathways lowest stock price was $2.25 and its highest was $7.53 in the past 12 months.

What is COMPASS Pathways’s market cap?

COMPASS Pathways’s market cap is $472.61M.

When is COMPASS Pathways’s upcoming earnings report date?

COMPASS Pathways’s upcoming earnings report date is Oct 30, 2025 which is in 48 days.

How were COMPASS Pathways’s earnings last quarter?

COMPASS Pathways released its earnings results on Jul 31, 2025. The company reported -$0.41 earnings per share for the quarter, beating the consensus estimate of -$0.433 by $0.023.

Is COMPASS Pathways overvalued?

According to Wall Street analysts COMPASS Pathways’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does COMPASS Pathways pay dividends?

COMPASS Pathways does not currently pay dividends.

What is COMPASS Pathways’s EPS estimate?

COMPASS Pathways’s EPS estimate is -0.4.

How many shares outstanding does COMPASS Pathways have?

COMPASS Pathways has 95,941,260 shares outstanding.

What happened to COMPASS Pathways’s price movement after its last earnings report?

COMPASS Pathways reported an EPS of -$0.41 in its last earnings report, beating expectations of -$0.433. Following the earnings report the stock price went up 10.406%.

Which hedge fund is a major shareholder of COMPASS Pathways?

Currently, no hedge funds are holding shares in CMPS

COMPASS Pathways Stock Smart Score

Neutral

Fundamentals

Return on Equity

-71.30%

Trailing 12-Months

Asset Growth

5.39%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

COMPASS Pathways

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

COMPASS Pathways (CMPS) Earnings & Revenues

Historic Earnings Reports

CMPS Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call reflected a generally optimistic outlook for COMPASS Pathways, with significant positive results in late-stage trials and a strong financial position. However, challenges remain, particularly in achieving FDA approval and addressing trial dropouts.View all CMPS earnings summaries

CMPS Stock 12 Month Forecast

Average Price Target

$15.44

▲(194.66% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","11":"$11","21":"$21","31":"$31","41":"$41"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$40.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.44,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$15.44</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$6.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,11,21,31,41],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.34,7.083076923076923,9.826153846153845,12.569230769230767,15.31230769230769,18.055384615384614,20.798461538461535,23.541538461538458,26.284615384615382,29.027692307692305,31.77076923076923,34.513846153846146,37.25692307692307,{"y":40,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.34,5.193846153846153,6.047692307692308,6.901538461538461,7.7553846153846155,8.60923076923077,9.463076923076922,10.316923076923077,11.170769230769231,12.024615384615384,12.878461538461538,13.732307692307693,14.586153846153845,{"y":15.44,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.34,4.467692307692308,4.595384615384615,4.723076923076923,4.850769230769231,4.978461538461539,5.1061538461538465,5.233846153846153,5.361538461538462,5.489230769230769,5.616923076923078,5.7446153846153845,5.872307692307692,{"y":6,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.95,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.88,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.48,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.96,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.75,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.78,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.31,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.93,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.79,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.37,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.16,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.34,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >